Request Information

EXCiPACT™ - Reducing the
Burden of Audits


Second Successful EXCiPACT™ Audit Including
ANSI Requirements

Internationally accepted certification scheme for pharmaceutical
excipient suppliers


EXCiPACT™Being one of the first companies to successfully complete a comprehensive EXCiPACT™ GMP&GDP audit 3 years ago, we successfully passed the first recertification audit in June 2016. This audit also covered the GMP requirements according to NSF/IPEC/ANSI -363-2014. With the new certificate, the compliance of our management system to both standards on GMP for Pharmaceutical Excipients was confirmed. The recertification is complemented by annual surveillance audits to control the continued quality of excipients.

What is EXCiPACT™?

Until 2013, there were no certifiable GMP and GDP (Good Manufacturing Practice, Good Distribution Practice) standards for the pharmaceutical excipients that make up the bulk of most drug formulations. So the pharmaceutical excipients industry launched EXCiPACT™ – a certification scheme for pharmaceutical excipients that grants an independent, one-stop ‘seal of approval’ by third-party auditors. With EXCiPACT™, a single audit will be all it takes to prove an excipient complies with current GMP and GDP requirements. This certification for manufacturers, suppliers and distributors of pharmaceutical excipients minimizes risks to customers and helps to reduce the burden of audits and thus costs.

Benefits:
    >
  • More safety: through certified compliance to recognized GMP and GDP standard
  • Cost and time savings: only a single audit is needed to prove GMP/GDP compliance
  • Worldwide acceptance: building on existing ISO standards, and supported by major industry organizations

What is NSF/IPEC/ANSI -363-2014?

Until 2015, there were no certifiable GMP and GDP standards for companies not applying the ISO 9001 Quality management standards. With NSF/IPEC/ANSI 363: Good Manufacturing Practices (GMP) for Pharmaceutical Excipients as the first American National Standard, this gap has been closed.

The new standard provides a harmonized and comprehensive set of criteria for the quality management systems used in the manufacture of pharmaceutical excipients worldwide. It was developed in partnership with the International Pharmaceutical Excipients Council (IPEC) with input coming from academic fields, industry and the U.S. Food and Drug Administration.

Excipient manufacturers with EXCiPACT™ and/or the NSF/IPEC/ANSI 363 standard certification demonstrate that their excipients are manufactured according to the appropriate GMPs for pharmaceutical use, representing the best industry practice currently available.

To learn more about EXCiPACT™ please visit www.excipact.org.
To learn more about NSF/IPEC/ANSI -363-2014, please click here